Espinoza Octavio

Average Profitability
<0.0001%
Insider Buys Quantity
0
Insider Buys Sum
$0
Insider Sells Quantity
6
Insider Sells Sum
$1.42M

Insider Activity of Espinoza Octavio

According to the SEC Form 4 filings, Espinoza Octavio, being in a position of

  1. Chief Financial Officer at Ligand Pharmaceuticals Incorporated,
    оver the last 12 months, has bought 0 shares, and sold 14708 shares for $1.29M,
    over all time since 2022-11-09, has bought 0 shares, and sold 16404 shares for $1.42M.

The largest sale of all time was on 2024-05-15 and amounted to 5873 shares of Ligand Pharmaceuticals Incorporated for $505,148.

Biography of Espinoza Octavio

No biography is available at this moment.

2024-09-20SaleLigand Pharmaceuticals Incorporated
LGND
Chief Financial Officer
1,275
0.0071%
$103.94$132,518-2.64%
2024-05-17SaleLigand Pharmaceuticals Incorporated
LGND
Chief Financial Officer
5,156
0.0289%
$86.66$446,844+16.22%
2024-05-16SaleLigand Pharmaceuticals Incorporated
LGND
Chief Financial Officer
2,264
0.0126%
$86.00$194,712+17.6%
2024-05-15SaleLigand Pharmaceuticals Incorporated
LGND
Chief Financial Officer
5,873
0.0328%
$86.01$505,148+16.25%
2024-02-28SaleLigand Pharmaceuticals Incorporated
LGND
Chief Financial Officer
140
0.0008%
$88.46$12,384-1.62%
2022-11-09SaleLigand Pharmaceuticals Incorporated
LGND
Chief Financial Officer
1,696
0.0101%
$75.64$128,283-6.95%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.